Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer — Stella

Home/Pancreatic Ductal Adenocarcinoma/Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

View on ClinicalTrials.gov

Recruiting

Back to Pancreatic Ductal Adenocarcinoma trials

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Trial locations(1 site)

United States

University of California, San Francisco, San Francisco, California

Key details

Sponsor

University of California, San Francisco

Collaborators

National Cancer Institute (NCI)

Enrollment target

~70 participants

Started

October 2024

Primary completion

August 2030

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.